Aspartic Protease Inhibitors

The present invention is directed to aspartic protease inhibitors. Certain aspartic protease inhibitors of the invention can be represented by the following structural formula or a pharmaceutically acceptable salt thereof. The present invention is also directed to pharmaceutical compositions compris...

Full description

Saved in:
Bibliographic Details
Main Authors TICE COLIN, DILLARD LAWRENCE W, SIMPSON ROBERT D, ISHCHENKO ALEXEY V, CLAREMON DAVID A, MCGEEHAN GERARD, YUAN JING, CACATIAN SALVACION, XU ZHENRONG, SINGH SURESH B, ZHAO WEI, FLAHERTY PATRICK T, BALDWIN JOHN J
Format Patent
LanguageEnglish
Published 25.02.2010
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to aspartic protease inhibitors. Certain aspartic protease inhibitors of the invention can be represented by the following structural formula or a pharmaceutically acceptable salt thereof. The present invention is also directed to pharmaceutical compositions comprising the disclosed aspartic protease inhibitors. The present invention is further directed to methods of antagonizing one or more aspartic proteases in a subject in need thereof, and methods for treating an aspartic protease mediated disorder in a subject using the disclosed aspartic protease inhibitors.
Bibliography:Application Number: US20060084928